Related by context. All words. (Click for frequent words.) 59 Antidumping Duties 59 Antitrust Litig 59 Patents Covering 58 Anti Dumping Duties 58 '# '# '# 58 Widely Used 57 Funds Declare Dividends 56 Resp 56 Injunctive Relief 56 Patent Infringement Claims 56 Temporary Suspension 55 Favorable Ruling 55 Arch Dermatol 55 Infringe 55 Restatement Process 55 Pending Litigation 55 Molecular Mechanism 55 Commercially Available 55 Patent Validity 55 Disclosure Requirement 55 Cell Phone Users 55 FDA Panel Recommends 55 Patents Issued 55 Acne Drug 55 Blood Clotting 54 Nationwide Voluntary Recall 54 CHMP Opinion 54 Pl. 54 Hip Implants 54 Pirated Software 54 Various Types 54 Data Suggest 54 Satellite Transponders 54 Inequitable Conduct 54 Generic Biologics 54 Low Dose 54 Risks Posed 54 Product Categories 54 Technological Advances 54 Blood Thinning 54 Rehearing En Banc 53 b#x# http:/#.#.#.#/fls.geo/PH #x# #.hyahrtzeit 53 Enforceability 53 Breast Cancer Genes 53 Patent Filings 53 Patent Covering 53 Protein Synthesis 53 Patent Infringement Lawsuit 53 Patent Lawsuit 53 Denture Cream 53 Patent Invalid 53 Patent Infringement Suit 53 Issues Resolved 53 Protein Biomarkers 53 Potential Dangers 53 Attorneys Fees 53 Inquiry Finds 53 Patented Technology 53 Def. s 53 Cholesterol Lowering Drug 53 Chip Makers 53 Defs. 53 #.#-# Convict Labor 53 #.#-# [001] 53 Reveals Significant 52 Pricing Structure 52 Patent Spat 52 Data Indicate 52 Report Analyzes 52 Anemia Drug 52 A.2 52 Results Indicate 52 Patent Dispute 52 Compl 52 Shareholder Lawsuits 52 Mln Share Buyback 52 Seriously Flawed 52 Material Facts 52 INDUSTRY DEFINITION Industry 52 Regulatory Approvals 52 Resp't 52 Cholinesterase Inhibitors 52 Advanced Colorectal Cancer 52 Genes Involved 52 Patent Infringement Case 52 Vigorously Defend 52 Differentiates 52 Patent Infringement 52 Files Patent Application 52 patrick.graham @ thomson.com 52 :# [002] 52 Patent Filing 52 Patents Upheld 52 Epidermal Growth Factor Receptor 52 FAR #.#-# [001] 52 AnaSpec Introduces 51 Incidents Involving 51 Treating Chronic 51 Antitrust Probe 51 False Marking 51 Veröffentlichung gemäß § 51 Patent Infringements 51 Trademark Dispute 51 Antitrust Laws 51 Nano Scale 51 Spoliation 51 See USSG 51 Per Capita Consumption 51 Vertebral Fracture 51 Comput 51 Settles Patent 51 Non Infringement 51 Investigational Agent 51 Misleading Advertising 51 Ultrasound Imaging 51 Upholds Ruling 51 Patent Infringement Lawsuits 51 Ephedra Ban 51 DFARS #.#-# 51 Drug Candidate 51 END FOOTNOTE * 51 Segregated Facilities 51 Patent Suits 51 Stmt 51 #.# subd [004] 51 FOIA Requests 51 GRAS Status 51 Bypass Vulnerability 51 TCA § #-#-# [003] 51 Antidumping 51 Affirmative Action Ban 51 Goodwill Impairment Charge 51 Accelerate Commercialization 51 Drug Makers 51 quoting Restatement Second 51 FDA Clears 51 Content Outline 51 Differentially 51 Textile Quotas 51 Arthritis Drug 51 -# -# [006] 51 Enhanced Capabilities 51 Infringed 51 Obviousness 51 Glucose Monitoring 50 Stem Cell Patents 50 Patent Infringement Litigation 50 Genetic Defect 50 Computer Glitch 50 AQUARIUS PLATINUM LIMITED 50 INTERNET LAW 50 Waste Mgmt 50 Patent Issued 50 Exclusive Licensee 50 Files Patent 50 Resolves Dispute 50 FDA Okays 50 Teva Provides Update 50 Arbitration Clauses 50 Certification Requirements 50 Quantum Dots 50 #d# [001] 50 FAR #.#-# [003] 50 CO2 Emission 50 Destroyed Evidence 50 FDA Clearance 50 Clinical Trial Results 50 Component Suppliers 50 Settle Patent 50 C.1 50 Generic Versions 50 Quicker Than 50 Preliminary Injunction Against 50 Concerns Raised 50 '# '# 50 Fee Structure 50 Liability Lawsuits 50 Tablet Formulation 50 See Restatement Second 50 Royalty Rates 50 Position Limits 50 File Sharers 50 Patent Infringement Claim 50 NAICS # [001] 50 Compulsory Licensing 50 Embryonic Stem Cells 50 Drug Coated Stent 50 SABESP Announces 50 FAR #.#-# Evaluation 50 Markets Examine 50 No. #-# Fed. 50 Competitive Scenario 50 Biologic Drugs 50 Implantable Medical 50 Issued Patent 50 Diamyd Medical Diamyd 50 Toy Recall 50 Must Carry 50 NIH Publication 50 Present Preclinical Data 50 Legal #.# 50 Patent Infringement Action 50 Dramatically Increases 50 Files Trademark 50 Heart Stents 50 Rheumatoid Arthritis Drug 50 USC § § #e 50 Proxy Disclosure 50 Monoclonal Antibody 50 De Minimis 50 Tumor Targeting 50 Submits NDA 50 Results Confirm 50 Antitrust Litigation 50 Asbestos Exposure 49 Income Tax Regs 49 Systemic Delivery 49 Announces Dismissal 49 Avian Flu Vaccine 49 CFR § #.# [008] 49 Gene Expression Analysis 49 Genetically Engineered Salmon 49 Immunomedics Announces 49 Begin Clinical Trials 49 WpHG mit dem Ziel 49 -irrelevancies 49 Enemy Combatant Case 49 - - [046] 49 Patent Ruling 49 iPhone Exclusivity 49 B.1 49 CFR Parts 49 Patent Suit 49 Copy Protected 49 Increased Incidence 49 Files Patent Infringement 49 Sustained Release 49 Trademark Infringement 49 Files IND 49 DC Code § 49 DVD Copying 49 Milestone Payment 49 entitled Compositions 49 Isomer 49 Progenitor Cell 49 Attenuating 49 FDA Approvals 49 Infringing 49 Compl. 49 CFR #.#b 49 Authorisations 49 OPERATING RESULT 49 Synthetic Peptide 49 Unsolicited Tender Offer 49 Shareholder Suits 49 CFR #.# [002] 49 Electronic Passports 49 Osteoporosis Drug 49 Confirms Validity 49 Antitrust Case 49 Generic Version 49 #.#.#.#.#.# 49 Disclosure Requirements 49 Blood Pressure Drug 49 cmt 49 Passive Component 49 Inhaled Insulin 49 #.#-# Instructions 49 INTRODUCTION I. 49 Acacia Subsidiary 49 Reporting Requirements 49 Lung Cancer Drug 49 Liquid Hydrocarbons 49 Early Termination 49 Provisional Patent 49 Malpractice Suit 49 #.# [023] 48 Testosterone Gel 48 Pricing Supplement 48 Evid 48 Counterfeit Drugs 48 Testosterone Patch 48 Sleep Apnea Diagnostic 48 Barcode Scanning 48 PremierWest Bancorp Announces 48 Metabolic Disorder 48 #.#-# b [001] 48 Guantánamo Detainees 48 Reply Brief 48 Blood Thinner 48 Economic Espionage 48 Migraine Drug 48 DTC Eligibility 48 PS § § 48 Nerve Agent 48 Gene Expression Profiles 48 FCC Rcd 48 -Richard Gitlen 48 Allstate Ins 48 Diagnostic Radiopharmaceuticals 48 Wins Patent Infringement 48 Mesothelioma Treatment 48 Derma Sciences Announces 48 Filing Requirements 48 3Gs 3G 48 DFARS 48 Arthritis Drugs 48 Summary Table 48 Settle Litigation 48 CFR § § #.# [001] 48 Substantial Shareholding 48 #.# - -Beart 48 Variable Interest Entities FIN 48 NO PAY PAL 48 Windows CurrentVersion Explorer 48 Approvable 48 Antitrust Ruling 48 Milestone Achieved 48 Receives Favorable Ruling 48 § § #-#-# [001] 48 Patent Broadly Covering 48 Permanent Injunction 48 Folding Cartons 48 Bone Graft Substitutes 48 Wins Summary Judgment 48 Buyer Respondents 48 Patent Disputes 48 EGFR HER2 48 Recombinant Proteins 48 -AND BENEFITS 48 Id. § 48 § #E 48 Denies Motion 48 BioElectronics Corporation Announces 48 Final Determination 48 Patentable 48 Antitrust Settlement 48 Metabolite 48 Chiral Technology 48 Gout Drug 48 J Exp Med 48 YEAR YEAR 48 Antitrust Violations 48 Stem Cell Treatment 48 Device Makers 48 Patent Reexamination 48 Trends Influencing 48 Clinical Trial Data 48 Transdermal Drug 48 #.#-# [016] 48 Valve Replacement 48 Holes Drilled 47 Offerors Commercial 47 #CV# 47 Announces FDA Clearance 47 Position EITF #-#-# 47 Initiates Patent Infringement 47 Contract Modifications 47 Infringement Case 47 Dangerous Substances 47 Output Declines 47 Induced Pluripotent Stem Cell 47 Load Structure 47 Bulk Ex Kandla 47 Patent Suit Against 47 Prostate Cancer Vaccine 47 Patent Nos. 47 § #a [002] 47 Act Pub. L. 47 Protease Inhibitor 47 Procedural Rules 47 NJSA 2C :5 47 Prof. Code § 47 Offeror Representations 47 Wound Dressing 47 Polymeric 47 Plant Explosion 47 -Amaka Anajemba 47 -0 Key 47 Dosage Strengths 47 C.3 47 ErP 47 Mylan Receives Approval 47 DOR BioPharma Announces 47 Patent Infringement Complaint 47 Firm Fined 47 Chp 47 Nanophase Announces 47 Self Contained 47 Incr 47 Miscellaneous Provisions 47 -#.# -#.# -#.# -#.# [006] 47 TCA § 47 Offerors Commercial Items 47 Ord. 47 Spears Conservatorship 47 :5 47 #.#.# [028] 47 False Advertising 47 Flights Delayed 47 Segment Highlights 47 Remote SQL Injection 47 Repl. 47 MCGUIRE K. 47 Uses Thereof 47 3d ed 47 Achieves Milestone 47 Infringement Suit 47 Piracy Crackdown 47 Practical Implications 47 Anti Dumping 47 CV# [001] 47 Tablet Device 47 Extraterritorial 47 EUR#.#B [002] 47 SFDA Approval 47 Confirms Efficacy 47 File Sharing Case 47 Offerors Commercial applies 47 TFT LCD Panels 47 Ovarian Cancer Treatment 47 #.#R #.#R [003] 47 Infrared Cameras 47 O. Reg 47 #.#-# b [002] 47 Expanded Indication 47 SIC Code 47 Implantable Defibrillators 47 #:# cv# [001] 47 Deadly Explosion 47 Evid. Code § § 47 Voluntary Dismissal 47 Invalidates 47 Positive Opinion 47 Plant Shutdowns 47 Method Patents 47 5TH CIR 47 -Ganga aarti 47 Permanent Injunction Against 47 Trend Towards 46 Not Infringe 46 Pretax Pft 46 xxx Domain 46 Antitrust Complaint 46 pawel.sobczak @ thomson.com 46 Grim Reminder 46 Provisional Regulations 46 #-#.# [016] 46 Patent Lawsuit Against 46 Wrinkle Treatment 46 Schizophrenia Drug 46 Container Vessels 46 Certifications Commercial Items 46 Method Developed 46 Cardiac Ablation 46 Intrinsically Safe 46 Contemplated 46 Organizational Restructuring 46 Segmental 46 +#.# pct [002] 46 TELEPERFORMANCE 46 Scientists Identify 46 EUR#.#.# 46 CFR #.# c 46 -1 -2 46 Acquisition Related 46 Miscellaneous Manufacturing 46 Fam. Code § 46 Has Doubled 46 Counterfeit Goods 46 Selling Stockholders 46 Coax Cable 46 Neuroendocrine Tumors 46 Infringes 46 Data Exclusivity 46 M2M Modules 46 CFR § #.# [003] 46 Patent Issuance 46 LIST OF FIGURES 46 Announces Favorable Ruling 46 Decision Upholding 46 Regulatory Clearance 46 #.#.i#.rpm 46 Injunction Against 46 Breast Implant 46 -Genereaux 46 § #-#.# [001] 46 Antidepressant Drug 46 Inorganic Chemicals 46 Announce Settlement 46 Antisense Oligonucleotides 46 Support #.# #.# 46 biotechnology Bioheart 46 § #:# [001] 46 Settle Dispute Over 46 GROUP TOTAL 46 Sector Shrinks 46 Newmont Declares Regular 46 Cost Overruns 46 Export Controls 46 MARKET TALK Doha 46 USC § #u 46 -Subscribes 46 CFR § § 46 Pollution Exclusion 46 WEIGHTED AVG 46 M Models Excluded 46 CFR § #.# [004] 46 Unfair Competition 46 Reconciliation Tables 46 Receives Patent 46 Settle Antitrust 46 #/#/EC [002] 46 Lentiviral 46 #/#/EC [001] 46 Ammunitions 46 Secures Patent 46 Legal Dispute 46 Begins Shipment 46 #B.# [002] 46 Online Drugstore 46 Ruling Upheld 46 MAIN FACTS 46 LECTRA 46 - - [062] 46 Settles Litigation 46 Initial Determination 46 Colo. Sess 46 Interpolated 46 Guidance Document 46 Insulation Materials 46 Receives Marketing Authorization 46 Cell Phone Makers 46 Accounting Pronouncements 46 See USSG § #B#.# 46 Regulatory Regime 46 Pharmingen units 46 #R #R #R [002] 46 Fast Track Status 46 para. 46 Rhinosinusitis 45 tupe 45 Marketing Authorisation 45 Analogs 45 Month Avg 45 Directory Traversal Vulnerability 45 Countersuit 45 Piracy Lawsuits 45 Awarded Patents 45 Receives SFDA Approval 45 Eligibility Requirements 45 Int J Epidemiol 45 Fuel Tank 45 Judgments § 45 -mock incredulity 45 #A #B [002] 45 Exch 45 Expense Income 45 Taxes Fees 45 BANJO 45 END FOOTNOTE FOOTNOTE 45 Polymer Blends 45 CFR § § #.# [002] 45 Hip Implant 45 Asthma Inhaler 45 Non Dilutive 45 Veterinary Surgeons Act 45 Tender Instructions 45 SEC Regulation SX 45 Patentability 45 Patent Infringement Lawsuit Against 45 P2P File Sharing 45 Circumvention 45 Liquid Hydrogen 45 -Reaster 45 #/#/EEC [002] 45 Recombinant Protein 45 Fire Extinguishing 45 NASDAQ Listing Requirements 45 Reexamination 45 Organizational Structure 45 Insulin Pen 45 Taro Receives 45 Measurement Devices 45 Forlax R 45 ll.# 45 Sharing Agreements 45 Recent Accounting Pronouncements 45 Okla. Stat 45 - - [116] 45 Humate P 45 weighted avg 45 Cancer Vaccines 45 #-#.# BID 45 HRS § 45 Amended Motion 45 с 45 END FOOTNOTE 45 Non Exempt 45 Generic Version Of 45 Intellectual Property Portfolio 45 Patriot Act Provisions 45 Settle Patent Litigation 45 ISIN Number 45 #M# #M# 45 Reference Document 45 COMPETITIVE ANALYSIS 45 oligonucleotides Manoharan 45 Antivirus Software 45 Has Entered 45 Bt Corn 45 Awarded Patent 45 Obtains Patent 45 Similac Recall 45 Formal Complaint 45 - - [126] 45 Bare Metal Stent 45 Prejudicial 45 First Amended Complaint 45 Consolidation Continues 45 Minimum Bid 45 Patent Upheld 45 Saprolite mafic intrusive 45 Option Grants 45 QUADRAMET R 45 Miraculins Announces 45 Va. Code § 45 Unenforceable 45 + - [013] 45 Miscellaneous Amendments 45 FAR #.#-# Instructions 45 § #-#-# [002] 45 Ordinance Cap. 45 [030] 45 DFAR #.#-# 45 E.1 45 Closing Dates 45 DLC Packs 45 Q#/# Q#/# Change 45 Derivative Action 45 Trademark Infringement Lawsuit 45 Goes Unnoticed 45 Skin Grafts 45 Exceptional Items 45 Operating Expense Ratio 45 Generating Units 45 § § #-# [001] 45 ft TW 45 Implementing Regulations 45 FDA Accepts 45 Administrative Proceeding 45 Explanatory Note 45 #.#-# Evaluation Commercial 45 Reconciling Items 45 KBRC# 45 FY# FY# FY# FY# [002] 45 Lockheed Martin Delivers 45 #.# [042] 45 Psoriasis Drug 45 Tamoxifen Citrate 45 CICA Accounting Guideline 45 Strained Silicon 45 High Temperature Superconductivity 45 #.#.# Jailbreak 45 Worker Rescued 44 Clin Orthop 44 AdvanSource Biomaterials Announces 44 Contracts § 44 Crash Shuts Down 44 Restructuring Expenses 44 NJSA #A 44 Vernon Supp 44 Bug Fix 44 Bus. & 44 Ionic Liquids 44 Pa.CS § 44 Dkt. 44 See id 44 nonoperating expense 44 CFR #.# [001] 44 -analyst Suki Cooper 44 CE Marked 44 Wiretap Evidence 44 Develop Innovative 44 Hit Snag 44 1.a. 44 - -winger Colby Armstrong 44 Transitional Provisions 44 Summary Judgment Motions 44 CFR § #.# [006] 44 # D# 44 - - [081] 44 Milestone Payments 44 Scientists Develop 44 Settle False Claims 44 #E #N 44 Invalidity 44 Buccal 44 Water Contamination 44 TAC - 44 KL4 Surfactant 44 Small Molecule 44 Restatement § 44 Summary Judgment Motion 44 Copyright Infringement 44 Interest Expenses 44 Somatostatin 44 SatBroadcasting 44 .W. McNichols 44 - -Leni Calas baby 44 Antiepileptic Drug 44 Connected Device 44 #.#-# [020] 44 Acta Psychiatrica Scandinavica 44 Compensators 44 VIOXX Product 44 -WIZO 44 Oregon Assisted Suicide 44 Fixed Dose Combination 44 WADA Prohibited List 44 Markman Hearing 44 NJSA 2C :2 44 Far Fetched 44 UNITS SOLD 44 OIL INVENTORIES Crude 44 AND SUBSIDIARIES CONSOLIDATED FINANCIAL 44 #.#-# Offeror Representations 44 communications@theratech.com 44 Ecallantide 44 Dominant Position 44 CFR § #.# [002] 44 Wiring Harness 44 Antiviral Therapeutics 44 Pa.RAP 44 Petroleum Refining Catalysts 44 therefore therapeutically equivalent 44 Judgment Debtors 44 Markman Ruling 44 Calorimetry 44 Specified Items 44 ENLIGHT 44 Terminations 44 EJ MAR# 44 Arms Export 44 b Vernon Supp 44 FY# FY# FY# 44 ACCOUNTING STANDARDS 44 ORBIT FR Reports 44 Month Euribor 44 - -Staehely 44 dated #.#.# [002] 44 Tenn. R. Civ 44 RC #.# B [001] 44 #.#A [001] 44 Jailbreak iPhone 3GS 44 Patent Infringement Suit Against 44 Wireless Number Portability 44 Railgun 44 MALVERN LINK 44 PDUFA Date 44 Obligor 44 Indemnities 44 Sequential Increase 44 Generic Protonix 44 Permanent Prostate Brachytherapy 44 Tst 44 Pro Forma EBITDA 44 ASCO Abstract 44 Intercreditor 44 Molecular Diagnostic 44 Compensation Expense 44 Antitrust Clearance 44 Continuous Disclosure 44 #CFR 44 Develop Novel 44 APPLICATION OF 44 Worker Finds 44 Increases Quarterly Distribution 44 -Elmers 44 § #:# [002] 44 [006] 44 Vioxx Suits 44 #,# #,# [004] 44 -Patney 44 NAICS code # 44 PlayBook Tablet 44 Exclusive License 44 - Operating [014] 44 Nucleic Acid 43 Use Thereof 43 CALJIC 43 Radilex TM 43 Second Amended Complaint 43 Remains Intact 43 2C :# 43 Obtains Exclusive License 43 GAAP Adj 43 Licensing Agreements 43 Discontinuing Operations 43 Contained Metal 43 VIVUS Announces 43 NET INCOME AS REPORTED 43 Unit Handling Equipment 43 CONTENTS Page 43 Financing Arrangement 43 Drill Rigs 43 Script Insertion Vulnerability 43 Coronary Revascularization 43 :9 43 Housing Starts Plunge 43 CEQA Guidelines 43 Licenses Patents 43 COMPANY OVERVIEW 43 Methylnaltrexone 43 Intermediation 43 R.# [001] 43 No. RE# [001] 43 Supplemental Biologics License Application 43 Court Dismisses Lawsuit 43 Takeovers Regulations 43 Promissory 43 Material Fact 43 Connected Transaction 43 Pharmacopoeia USP 43 H 1B Visa 43 :3 43 Pa.CSA § 43 Summary Judgment Order 43 fcmi buying 43 Patent Application 43 Gross Premiums Written 43 FAR Clause #.#-# 43 i#.rpm 43 Accesses 43 #.#-# [006] 43 #.#.# [011] 43 #.#.# #:#:# = 43 Successful Completion 43 Investigational Drugs 43 Blast Furnaces 43 DCID 6 43 Remium AB 43 Announces Tentative Approval 43 Fuel Tanks 43 Declaratory Relief 43 Surveillance Criteria 43 R'# R'# R'# R'# 43 RESTATEMENT SECOND OF 43 IFRS IFRS 43 Currency Conversion 43 Annexures 43 Prohibited List 43 directive #/#/EC [002] 43 Launch Date 43 NJSA #:# C 43 Listing Application 43 Output Grows 43 D.2 43 - - [034] 43 § #.# [002] 43 RNAi Therapeutics 43 + - [018] 43 Explanatory Notes 43 #.# subds [001] 43 Particle Collider 43 constitutes discloseable transaction 43 -#,# -#.# [001] 43 USC § #a [002] 43 - -Ker WingHouse Bar 43 ASME Boiler 43 classes #A# #A# 43 - -Cavlan 43 Recurring Adj 43 Pad Printing 43 #b [004] 43 Interdigital 43 Subcon ITC Action 43 -Expandable Memory 43 Penwest Pharmaceuticals Co 43 Convertible Notes Due 43 Jury Verdict 43 Production Capacities 43 4th Qtr 4th Qtr 43 Drug Eluting Coronary Stent 43 Tafas v. Doll 43 Valganciclovir 43 EBITDA Margin 43 Infringing Products 43 v#.#.# [003] 43 Tape Recording 43 CFR #.# [005] 43 § #-#-# b [001] 43 USLW 43 CFR #.# [008] 43 NASDAQ Listing 43 Patent Litigation 43 #.# - -Arbab Ghulam Rahim 43 Divested Businesses 43 Le Numero 43 #.# subd [003] 43 Fiber Optic Cables 43 Final Stages 43 Safe Harbor Disclosure 43 #-#.# [014] 43 SEBI ICDR Regulations 43 -John F. Biemeck 43 § #-# [004] 43 Distribution Agreements 43 RESTRUCTURING COSTS 43 AuEq g t 43 Pension Obligations 43 -Rejustors 43 Cu Eq 42 Product Tanker 42 Amended Petition 42 § #a [003] 42 ROCA Reports 42 CFR pt 42 Long Term Lease 42 FAR #.# 42 Sinorgchem 42 NOTIFICATION OF MAJOR INTERESTS 42 § #A.# 42 Stock Compensation Expense 42 Claims Trademarks Patents 42 Antibody Discovery 42 NASDAQ Delisting Notice 42 theSecurities Act 42 Accelerated Approval 42 Id. ¶ 42 Anthrax Scare 42 #,#,# B2 42 Arbitrary Code 42 § #.# [003] 42 Encision Reports 42 Regulations Governing 42 NAVAL AIR 42 Anti Nausea 42 Hereinafter 42 USCS § 42 § #-#-# [001] 42 Preemption 42 See TCA § 42 USC § #d 42 Immune Therapy 42 Slides Into 42 QVC Item 42 Processing Ethanol Byproducts 42 Settles Patent Infringement Lawsuit 42 § #.#-# [004] 42 Generic Lipitor 42 Earns Milestone Payment 42 piotr.skolimowski @ thomson.com 42 § #-#-#.# 42 Biochip 42 www.solvay.com 42 Numbering System 42 Parallel Processing 42 -tau gene 42 ADAAG 42 Aircastle Announces 42 Patriot Act Reauthorization 42 Pecuniary 42 Market Restraints 42 CFR § #.#b 42 ONGLYZA TM 42 Hatch Waxman Amendments 42 CFR § #.# [001] 42 Intellectual Property Infringement 42 Proposed Arrangement 42 Procurement Procedures 42 Vehicular Lighting 42 CORPORATE GOVERNANCE STATEMENT 42 Immunocytometry Systems 42 Constant Currency 42 NZX Listing Rules 42 READER ADVISORY 42 Authorized Generic 42 § #-#-# b [003] 42 #.#-# [005] 42 #.# subd [006] 42 D# [004] 42 Net Unrealized Gains 42 ICANN Approves 42 #Q'# #Q'# #Q'# #Q'# 42 Hip Prosthesis 42 Kaukomarkkinat 42 Exercise Notices 42 [013] 42 GLc 42 Conversion Ratio 42 Object Recognition 42 Announce License Agreement 42 Biosimilar 42 eBulletin 42 =shen 42 .execute arbitrary SQL 42 = sizeof 42 Ref.